Report of Foreign Issuer

Telix Pharmaceuticals Ltd Filed 2026-09-14 Acc 0001628280-26-061892

Documents 1

2026-09-21 6-K Report of Foreign Issuer
2026-09-14 4 Group Chief Financial Officer bought 2,071 shares at $9.66 ($19,998)
2026-09-14 6-K Report of Foreign Issuer
2026-09-02 6-K Report of Foreign Issuer

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading telix-6kpixclarafdaapproval.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…